Join
Live feed
·
INSIDERFilingvia Quantisnow
Jazz Pharmaceuticals plc logo

EVP, Global Head of R&D & CMO Iannone Robert sold $1,204,573 worth of Ordinary Shares (7,159 units at $168.26), decreasing direct ownership by 9% to 72,628 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
JAZZ· Jazz Pharmaceuticals plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAZZ (Jazz Pharmaceuticals plc) and more on Quantisnow.